MTOR and cancer: As a dual inhibitor of phosphatidylinositide 3 kinase (PI3K)/mammalian target of rapamycin (mTOR), NVP‐BEZ235 (called BEZ235 thereafter) could exert antitumor effects and induce cancer cell apoptosis in multiple trials 6, 7.